Best TWAS P=4.66e-13 · Best GWAS P=2.27e-10 conditioned to 0.64
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | CommonMind | Brain Pre-frontal Cortex | METTL10 | 0.20 | 0.26 | lasso | 9 | 0.26 | 4.5e-31 | -6.1 | -5.8 | 6.9e-09 | 0.98 | 0.02 | 0.98 | FALSE |
2 | GTEx | Brain Caudate basal ganglia | METTL10 | 0.33 | 0.16 | lasso | 3 | 0.18 | 7.6e-06 | 4.4 | -5.4 | 5.7e-08 | 0.76 | 0.03 | 0.95 | FALSE |
3 | GTEx | Brain Cerebellum | METTL10 | 0.25 | 0.05 | enet | 25 | 0.08 | 2.4e-03 | -4.0 | -5.5 | 4.7e-08 | 0.70 | 0.03 | 0.89 | FALSE |
4 | GTEx | Lung | METTL10 | 0.11 | 0.06 | enet | 6 | 0.05 | 1.7e-04 | -6.1 | -5.9 | 4.3e-09 | 0.95 | 0.02 | 0.98 | FALSE |
5 | GTEx | Testis | METTL10 | 0.26 | 0.14 | lasso | 9 | 0.08 | 2.3e-04 | -6.1 | -5.5 | 3.1e-08 | 0.96 | 0.02 | 0.98 | FALSE |
6 | METSIM | Adipose | METTL10 | 0.12 | 0.15 | enet | 27 | 0.15 | 1.1e-21 | -6.1 | -6.0 | 2.1e-09 | 0.95 | 0.01 | 0.99 | FALSE |
7 | ROSMAP | Brain Pre-frontal Cortex | METTL10 | 0.14 | 0.16 | lasso | 7 | 0.18 | 5.5e-22 | -3.7 | -5.3 | 1.3e-07 | 0.93 | 0.01 | 0.99 | FALSE |
8 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | METTL10 | 0.09 | 0.08 | blup | 43 | 0.11 | 1.2e-09 | -6.1 | -6.1 | 1.2e-09 | 0.96 | 0.01 | 0.99 | FALSE |
9 | The Cancer Genome Atlas | Breast Invasive Carcinoma | METTL10 | 0.06 | 0.13 | lasso | 7 | 0.13 | 1.1e-25 | -6.0 | -6.0 | 2.5e-09 | 0.99 | 0.02 | 0.98 | FALSE |
10 | The Cancer Genome Atlas | Colon Adenocarcinoma | METTL10 | 0.09 | 0.14 | lasso | 9 | 0.12 | 3.1e-07 | -5.9 | -5.9 | 3.8e-09 | 0.99 | 0.02 | 0.98 | FALSE |
11 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | METTL10 | 0.10 | 0.14 | blup | 43 | 0.14 | 7.4e-16 | -6.1 | -5.9 | 3.8e-09 | 0.98 | 0.02 | 0.98 | FALSE |
12 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | METTL10 | 0.10 | 0.16 | lasso | 7 | 0.17 | 1.0e-18 | -6.1 | -5.6 | 1.8e-08 | 0.97 | 0.01 | 0.99 | FALSE |
13 | The Cancer Genome Atlas | Kidney Renal Papillary Cell Carcinoma | METTL10 | 0.11 | 0.12 | lasso | 5 | 0.13 | 8.4e-08 | -6.1 | -5.8 | 6.2e-09 | 0.98 | 0.02 | 0.98 | FALSE |
14 | The Cancer Genome Atlas | Brain Lower Grade Glioma | METTL10 | 0.13 | 0.16 | blup | 43 | 0.18 | 1.8e-20 | -6.1 | -5.8 | 5.0e-09 | 0.91 | 0.02 | 0.98 | FALSE |
15 | The Cancer Genome Atlas | Liver Hepatocellular Carcinoma | METTL10 | 0.11 | 0.08 | blup | 43 | 0.12 | 4.8e-06 | -6.2 | -5.7 | 1.5e-08 | 0.96 | 0.01 | 0.98 | FALSE |
16 | The Cancer Genome Atlas | Lung Adenocarcinoma | METTL10 | 0.11 | 0.19 | lasso | 6 | 0.19 | 7.3e-22 | -6.1 | -6.1 | 1.1e-09 | 0.99 | 0.01 | 0.99 | FALSE |
17 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | METTL10 | 0.05 | 0.06 | blup | 43 | 0.07 | 4.6e-08 | -6.3 | -6.5 | 1.1e-10 | 0.96 | 0.01 | 0.99 | FALSE |
18 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | METTL10 | 0.05 | 0.06 | lasso | 4 | 0.06 | 9.2e-05 | -5.3 | -5.7 | 1.4e-08 | 0.93 | 0.02 | 0.96 | FALSE |
19 | The Cancer Genome Atlas | Pancreatic Adenocarcinoma | METTL10 | 0.18 | 0.13 | enet | 12 | 0.11 | 2.4e-05 | -6.0 | -7.2 | 4.7e-13 | 0.90 | 0.01 | 0.98 | TRUE |
20 | The Cancer Genome Atlas | Pheochromocytoma and Paraganglioma | METTL10 | 0.09 | 0.10 | lasso | 2 | 0.06 | 1.5e-03 | -5.9 | -6.2 | 4.3e-10 | 0.95 | 0.02 | 0.93 | FALSE |
21 | The Cancer Genome Atlas | Prostate Adenocarcinoma | METTL10 | 0.10 | 0.17 | blup | 43 | 0.18 | 1.9e-18 | -6.0 | -5.3 | 1.1e-07 | 0.93 | 0.02 | 0.98 | FALSE |
22 | The Cancer Genome Atlas | Stomach Adenocarcinoma | METTL10 | 0.07 | 0.07 | lasso | 4 | 0.07 | 6.2e-06 | -3.7 | -5.2 | 1.8e-07 | 0.92 | 0.02 | 0.98 | FALSE |
23 | The Cancer Genome Atlas | Thyroid Carcinoma | METTL10 | 0.25 | 0.35 | lasso | 5 | 0.36 | 5.9e-36 | -6.1 | -6.0 | 2.4e-09 | 0.98 | 0.01 | 0.99 | FALSE |
24 | The Cancer Genome Atlas | Uterine Corpus Endometrial Carcinoma | METTL10 | 0.13 | 0.08 | blup | 43 | 0.12 | 2.4e-04 | -6.1 | -6.0 | 1.5e-09 | 0.96 | 0.01 | 0.93 | FALSE |